1. Bronstein, M. D. (2011). Cushing’s Syndrome: Pathophysiology, Diagnosis and Treatment. Estados Unidos: Humana Press.
2. Gupta, A., & Gupta, Y. (2013). Glucocorticoid-induced myopathy: Pathophysiology, diagnosis, and treatment. Indian Journal of Endocrinology and Metabolism, 17(5), 913–916. http://doi.org/10.4103/2230-8210.117215
3. Isidori, A. M., Graziadio, C., Paragliola, R. M., Cozzolino, A., Ambrogio, A. G., Colao, A. (2015). The hypertension of Cushing’s syndrome: controversies in the pathophysiology and focus on cardiovascular complications. Journal of Hypertension, 33(1), 44–60. http://doi.org/10.1097/HJH.0000000000000415
4. Kaltsas, G., & Makras, P. (2010). Skeletal diseases in Cushing’s syndrome: osteoporosis versus arthropathy. Neuroendocrinology, 92(Suppl. 1), 60-64.
5. Kim, S. Y., Davydov, O., Hans, D., & Bockman, R. (2015). Insights on accelerated skeletal repair in Cushing’s disease. Bone reports, 2, 32-35.
6. Manubolu, S., & Nwosu, O. (2017). Exogenous Cushing’s syndrome secondary to intermittent high dose oral prednisone for presumed asthma exacerbations in the setting of multiple emergency department visits. Journal of Clinical and Translational Endocrinology: Case Reports, 6, 4-8.
7. Sacerdote, A., Weiss, K., Tran, T., Noor, B. R., & McFarlane, S. I. (2005). Hypertension in patients with Cushing’s disease: pathophysiology, diagnosis, and management. Current hypertension reports, 7(3), 212-218.

The download will start shortly.